DSGX
The Descartes Systems Group Inc.
DSGX's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over DSGX overall, supported by stronger modeled upside and stronger valuation.
DSGX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
DSGX's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
DSGX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 37x | $95.47 | — |
| Current | 43x | $95.47 | — |
| Cheap | 56x | $123 | +29% |
| Fair | 68x | $150 | +57% |
| Expensive | 110x | $242 | +154% |
Historical ranges are pointers, not guarantees.
DSGX's PE is in its cheap range at 43x. If earnings grow as analysts expect, today's price would be 37x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over DSGX in the historical PE scenario, which offers more potential upside but is not a forecast.
DSGX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
DSGX has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
DSGX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +17% |
| Q3 2026 | $2.20 | +30% |
| Q2 2026 | $2.06 | +24% |
| Q1 2026 | $1.91 | +16% |
| Q4 2025 | $1.77 | +11% |
| Q3 2025 | $1.69 | +15% |
| Q2 2025 | $1.66 | +19% |
| Q1 2025 | $1.65 | +24% |
| Q4 2024 | $1.59 | +21% |
DSGX's earnings per share have climbed steadily: $2.20 over the past year, up 30% from the year before, and higher year over year every quarter since late 2020.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over DSGX on earnings, with stronger typical year-over-year growth.
DSGX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.1M | +12% |
| Q2 2026 | $193.6M | +15% |
| Q1 2026 | $194.6M | +16% |
| Q4 2025 | $185.8M | +10% |
| Q3 2025 | $179.8M | +10% |
| Q2 2025 | $168.7M | +11% |
| Q1 2025 | $167.5M | +13% |
| Q4 2024 | $168.8M | +17% |
DSGX's revenue has grown year over year every quarter since late 2020: $201M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | +6.4 points |
| Q2 2026 | 33% | +5.5 points |
| Q1 2026 | 33% | +5 points |
| Q4 2025 | 33% | +6 points |
| Q3 2025 | 27% | -1.3 points |
| Q2 2025 | 27% | -0.6 points |
| Q1 2025 | 28% | +3.1 points |
| Q4 2024 | 27% | +4.7 points |
DSGX's operating margin was 33% last quarter, up 6.4 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over DSGX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over DSGX on profitability, with a higher operating margin.
DSGX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.9M | +27% |
| Q2 2026 | $73.2M | +41% |
| Q1 2026 | $75.9M | +30% |
| Q4 2025 | $71.5M | +22% |
| Q3 2025 | $62.1M | +88% |
| Q2 2025 | $51.7M | -15% |
| Q1 2025 | $58.6M | +16% |
| Q4 2024 | $58.8M | +7.8% |
DSGX's free cash flow has been positive every quarter for seven years: $300M over the past year, up 29% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over DSGX on cash flow, with stronger typical year-over-year growth.
DSGX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -334K shares |
| 1 year | -0.6% | -530K shares |
| 3 years | +0.3% | +277K shares |
| 5 years | +1.1% | +932K shares |
| Available history | +2% | +1.7M shares |
DSGX has 87M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $24.2M |
| Q2 2026 | $21M |
| Q1 2026 | $911,573 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
DSGX spent $46M buying back its own shares over the past year, after none the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over DSGX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
DSGX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
DSGX has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DSGX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.7 | Neutral |
| Stochastic | 89.2 | Overbought |
DSGX's weekly RSI is 67 (neutral) and its Stochastic is 89 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
DSGX PE vs Technology Sector
| Metric | DSGX | Sector median | Relative |
|---|---|---|---|
| PE | 43x | 28x | 56% above |
| PE % | 11 | 35 | 24 pts below |
DSGX is trading at 43x earnings, a 56% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over DSGX on valuation relative to its sector.
DSGX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $87.8 | 8.7% above |
| 20 week MA | $80.7 | 18% above |
| 50 week MA | $77.5 | 23% above |
| 100 week MA | $90.4 | 5.6% above |
| 200 week MA | $88.9 | 7.5% above |
DSGX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
DSGX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.7 | $59.7 | +40% |
| 2021 | $59.7 | $80.9 | +36% |
| 2022 | $80.9 | $68.5 | -15% |
| 2023 | $68.5 | $84.1 | +23% |
| 2024 | $84.1 | $114.0 | +36% |
| 2025 | $114.0 | $89.4 | -22% |
| 2026 YTD | $89.4 | $95.5 | +6.7% |
DSGX has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.